跳至主要内容
临床试验/IRCT20180929041169N2
IRCT20180929041169N2招募中2 期

Comparison of efficacy of low dose of Atorvastatin and Rosuvastatin versus high dose of Atorvastatin and Rosuvastatin in reducing hs-CRP and IL-6 in diabetic patient referred to the Institute of Endocrinology and Metabolism

Iran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 75 years(—)
性别
All

入选标准

  • Diabetic patients who need to receive Statin according to ADA 2018

排除标准

  • Patient with Genetic Disease
  • Use of other lowering agent other than Statin
  • Hx of Angina
  • Hx of Nephropathy
  • Hx of Hypothyroidism
  • Hx of liver Disease or ALT> 3 ULN,AST>3 ULN
  • CPK> 10 ULN
  • Patients on Corticosteroids
  • Patients with Cyclosporins or Hormone replacement therapy
  • Hx of use of Alcohol
  • Acute and chronic infectious or Inflammatory disease

研究者

相似试验